Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 5
Submit an article Journal homepage
404
Views
32
CrossRef citations to date
0
Altmetric
Original Research

A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function

Mariano Malaguarnera
,
Marco Vacante University of Catania, Urological and Neurological Sciences, Department of Senescence, Ospedale Cannizzaro, Viale Messina 829, 95125 Catania, Italy +39 957 262 008; +39 957 262 011; [email protected]
,
Cristina Russo University of Catania, Urological and Neurological Sciences, Department of Senescence, Ospedale Cannizzaro, Viale Messina 829, 95125 Catania, Italy +39 957 262 008; +39 957 262 011; [email protected]
,
Giovanna Dipasquale University of Catania, Urological and Neurological Sciences, Department of Senescence, Ospedale Cannizzaro, Viale Messina 829, 95125 Catania, Italy +39 957 262 008; +39 957 262 011; [email protected]
,
Maria Pia Gargante University of Catania, Urological and Neurological Sciences, Department of Senescence, Ospedale Cannizzaro, Viale Messina 829, 95125 Catania, Italy +39 957 262 008; +39 957 262 011; [email protected]
&
Massimo Motta University of Catania, Urological and Neurological Sciences, Department of Senescence, Ospedale Cannizzaro, Viale Messina 829, 95125 Catania, Italy +39 957 262 008; +39 957 262 011; [email protected]
Pages 737-742 | Published online: 07 May 2009

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Heather P. May, Kristin C. Mara, Erin F. Barreto, Nelson Leung & Thomas M. Habermann. (2021) Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome. Leukemia & Lymphoma 62:13, pages 3152-3159.
Read now
Giulia Malaguarnera, Maria Giordano & Mariano Malaguarnera. (2012) Rasburicase for the treatment of tumor lysis in hematological malignancies. Expert Review of Hematology 5:1, pages 27-38.
Read now

Articles from other publishers (30)

Anthony J. Perissinotti, Michael R. Bishop, Joseph Bubalo, Mark B. Geyer, Amy Goodrich, Scott C. Howard, Julianna Kula, Sreedhar Mandayam, Mitchell S. Cairo & Ching-Hon Pui. (2023) Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel. Cancer Treatment Reviews 120, pages 102603.
Crossref
Giovanna Leoncini, Cecilia Barnini, Luca Manco, Giulia Nobili, Daniele Dotta, Martina Penso, Elisa Russo, Francesca Cappadona, Francesca Viazzi & Roberto Pontremoli. (2022) Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?. Clinical Kidney Journal 15:9, pages 1666-1674.
Crossref
Gabriela Lupușoru, Ioana Ailincăi, Georgiana Frățilă, Oana Ungureanu, Andreea Andronesi, Mircea Lupușoru, Mihaela Banu, Ileana Văcăroiu, Constantin Dina & Ioanel Sinescu. (2022) Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology. Biomedicines 10:5, pages 1012.
Crossref
Lewena Maher, John E. Oghene & Anthony M. Reginato. 2022. Rheumatology for Primary Care Providers. Rheumatology for Primary Care Providers 147 210 .
Federica Fogacci, Claudio Borghi, Antonio Di Micoli, Daniela Degli Esposti & Arrigo F.G. Cicero. (2021) Inequalities in enrollment of women and racial minorities in trials testing uric acid lowering drugs. Nutrition, Metabolism and Cardiovascular Diseases 31:12, pages 3305-3313.
Crossref
Yuka Sato, Daniel I. Feig, Austin G. Stack, Duk-Hee Kang, Miguel A. Lanaspa, A. Ahsan Ejaz, L. Gabriela Sánchez-Lozada, Masanari Kuwabara, Claudio Borghi & Richard J. Johnson. (2019) The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD. Nature Reviews Nephrology 15:12, pages 767-775.
Crossref
Donald J. WeaverJrJr. (2018) Uric acid and progression of chronic kidney disease. Pediatric Nephrology 34:5, pages 801-809.
Crossref
Lei Tao, Dandan Li, Yonghong Li, Xinchang Shi, Junzhi Wang, Chunming Rao & Yingqi Zhang. (2017) Designing a mutant Candida uricase with improved polymerization state and enzymatic activity. Protein Engineering, Design and Selection 30:11, pages 753-759.
Crossref
Theodoros Eleftheriadis, Spyridon Golphinopoulos, Georgios Pissas & Ioannis Stefanidis. (2017) Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial. Journal of Advanced Research 8:5, pages 555-560.
Crossref
Maria Erika G. Ramirez & Joanne M. Bargman. (2017) Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review. Journal of Advanced Research 8:5, pages 551-554.
Crossref
Young-Woo Jeon, Dae-Hun Kwak, Sung-Soo Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Chang-Ki Min, Jong-Wook Lee, Woo-Sung Min & Seok-Goo Cho. (2017) Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome. Clinical Lymphoma Myeloma and Leukemia 17:9, pages 595-603.
Crossref
N.P. Nickel, J.M. O’Leary, E.L. Brittain, J.P. Fessel, R.T. Zamanian, J.D. West & E.D. Austin. (2017) Kidney dysfunction in patients with pulmonary arterial hypertension. Pulmonary Circulation 7:1, pages 38-54.
Crossref
Fan Lin, Hailin Zhang, Feng Huang, Hui Chen, Chunjin Lin & Pengli Zhu. (2016) Influence of changes in serum uric acid levels on renal function in elderly patients with hypertension: a retrospective cohort study with 3.5-year follow-up. BMC Geriatrics 16:1.
Crossref
Tahir Kanji, Mandark Gandhi, Catherine M Clase & Robert Yang. (2015) Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrology 16:1.
Crossref
M. Spina, Z. Nagy, J.M. Ribera, M. Federico, I. Aurer, K. Jordan, G. Borsaru, A.S. Pristupa, A. Bosi, S. Grosicki, N.L. Glushko, D. Ristic, J. Jakucs, P. Montesinos, J. Mayer, E.M. Rego, S. Baldini, S. Scartoni, A. Capriati, C.A. Maggi & C. Simonelli. (2015) FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Annals of Oncology 26:10, pages 2155-2161.
Crossref
Lisa M. Barbarotta. 2015. Critical Care Nursing. Critical Care Nursing 167 200 .
Frances Rees, Michelle Hui & Michael Doherty. (2014) Optimizing current treatment of gout. Nature Reviews Rheumatology 10:5, pages 271-283.
Crossref
F. Perry Wilson & Jeffrey S. Berns. (2014) Tumor Lysis Syndrome: New Challenges and Recent Advances. Advances in Chronic Kidney Disease 21:1, pages 18-26.
Crossref
Kim Hughes, Tanya Flynn, Janak de Zoysa, Nicola Dalbeth & Tony R. Merriman. (2014) Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. Kidney International 85:2, pages 344-351.
Crossref
Huan Wang, Yong Wei, Xianglei Kong & Dongmei Xu. (2013) Effects of Urate-Lowering Therapy in Hyperuricemia on Slowing the Progression of Renal Function: A Meta-Analysis. Journal of Renal Nutrition 23:5, pages 389-396.
Crossref
X. Feng, K. Dong, D. Pham, S. Pence, J. Inciardi & N. S. Bhutada. (2013) Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis. Journal of Clinical Pharmacy and Therapeutics 38:4, pages 301-308.
Crossref
Jesse DawsonPanniyammakal JeemonLucy HetheringtonCaitlin JuddClaire HastieChristin SchulzWilliam SloanScott MuirAlan JardineGordon McInnesDavid MorrisonAnna F. DominiczakSandosh PadmanabhanMatthew Walters. (2013) Serum Uric Acid Level, Longitudinal Blood Pressure, Renal Function, and Long-Term Mortality in Treated Hypertensive Patients. Hypertension 62:1, pages 105-111.
Crossref
. (2013) References. Kidney International Supplements 3:1, pages 136-150.
Crossref
. (2013) Chapter 5: Referral to specialists and models of care. Kidney International Supplements 3:1, pages 112-119.
Crossref
. (2013) Chapter 3: Management of progression and complications of CKD. Kidney International Supplements 3:1, pages 73-90.
Crossref
F. Perry Wilson & Jeffrey S. Berns. (2012) Onco-Nephrology. Clinical Journal of the American Society of Nephrology 7:10, pages 1730-1739.
Crossref
. (2012) Current World Literature. Current Opinion in Rheumatology 24:2, pages 237-244.
Crossref
Massimo Motta, Cristina Russo, Marco Vacante, Rocco Luca Emanuele Liardo, Francesca Reitano, Lisa Cammalleri, Mario Costanzo, Giuseppe Benfatto, Paola Frazzetto, Enrico Mondati, Michele Malaguarnera & Giovanni Pennisi. (2011) Losartan vs. amlodipine treatment in elderly oncologic hypertensive patients: A randomized clinical trial. Archives of Gerontology and Geriatrics 53:1, pages 60-63.
Crossref
Miriam Giraldez & Katarzyna Puto. (2010) A single, fixed dose of rasburicase (6 mg maximum) for treatment of tumor lysis syndrome in adults. European Journal of Haematology 85:2, pages 177-179.
Crossref
Andrew Whelton. (2010) Current and Future Therapeutic Options for the Management of Gout. American Journal of Therapeutics 17:4, pages 402-417.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.